Drug resistance or impaired immunity against the coronavirus are likely not the cause of rebound symptoms some patients experience after taking Pfizer’s antiviral Paxlovid, according to a new study from University of California San Diego researchers.
Read the full post on Becker's Hospital Review - Healthcare News
